Nov 14 (Reuters) - 2cureX AB 2CUREX.ST :
* 2CUREX DISCLOSES STATUS OF 2022 PLANS, GOALS FOR 2023 AND
ITS
ESTIMATES OF POTENTIAL MARKET DEVELOPMENT IN THE COMING YEARS
* OUTLOOK 2023: STRATEGY REMAINS UNCHANGED -- TO FOCUS ON
EUROPEAN
REGION (BUT OPEN TO OPPORTUNITIES FOR COLLABORATION IN US AND
MIDDLE EAST) AND IN AREA OF COLORECTAL CANCER
* KPIS TO MONITOR ACTIVITIES SET FOR 2023 INCLUDE 2
CLINICAL
STUDIES STARTED
* KPIS TO MONITOR ACTIVITIES SET FOR 2023 INCLUDE >6 M SEK,
OF
WHICH 3M SEK FROM SALES ( REST COMING FROM GRANTS OR OTHER
SOURCES)
Source text for Eikon: ID:nMFN93DtG1
Further company coverage: 2CUREX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))